Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)

Inclusion Criteria:

- Man or woman from 18 years old and without upper age limit

- Patient followed in pulmonology at Strasbourg University Hospital

- Patient presenting at least one of the following pathologies:

1. severe persistent asthma (200 patients)

2. chest cancer that is active or has received treatment within a period of less
than one year (300 patients)

3. history of lung transplantation performed before the start of the epidemic
(02/29/2020) (300 patients)

4. idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis
(70 patients)

5. pulmonary arterial hypertension (PAH) (group 1 of the international
classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)

6. Severe COPD in the respiratory failure stage (150 patients)

- Subject affiliated to a social health insurance protection scheme

- Subject able to understand the objectives of the research

- Subject having signed an informed consent

Exclusion Criteria:

- Inability to provide informed information about the subject (subject in an emergency
situation, difficulty in understanding the subject, etc.)

- Subject under safeguard of justice

- Subject under guardianship or guardianship